BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18525304)

  • 1. ERK signaling in colorectal cancer: a preliminary report on the expression of phosphorylated ERK and the effects of radiation therapy.
    Corn BW; Kovner F; Bek S; Wexler I; Lifschits B; Seger R
    Am J Clin Oncol; 2008 Jun; 31(3):255-8. PubMed ID: 18525304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High nuclear expression of phosphorylated extracellular signal-regulated kinase in tumor cells in colorectal glands is associated with poor outcome in colorectal cancer.
    Tai CJ; Lee CH; Chen HC; Wang HK; Jiang MC; Su TC; Shen KH; Lin SH; Yeh CM; Chen CJ; Yeh KT; Chang CC
    Ann Diagn Pathol; 2013 Apr; 17(2):165-71. PubMed ID: 23183114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal tumors frequently express phosphorylated mitogen-activated protein kinase.
    Lee SH; Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Kim SH; Yoo NJ; Lee JY
    APMIS; 2004; 112(4-5):233-8. PubMed ID: 15233637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.
    Gulmann C; Sheehan KM; Conroy RM; Wulfkuhle JD; Espina V; Mullarkey MJ; Kay EW; Liotta LA; Petricoin EF
    J Pathol; 2009 Aug; 218(4):514-9. PubMed ID: 19396842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
    Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
    Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations.
    Chow S; Hedley D; Grom P; Magari R; Jacobberger JW; Shankey TV
    Cytometry A; 2005 Sep; 67(1):4-17. PubMed ID: 16080188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
    de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
    Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.
    Zhang S; Qiu X; Gu Y; Wang E
    Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.